cagrilintide/semaglutide VisualAbstract: Combined cagrilintide and semaglutide for weight management well-tolerated in early clinical trials Cagrilintide / Semaglutide Blend (5mg

Feeling sluggish and lacking energy

For example, women often reach toxic BAC levels with fewer drinks than men because of differences in body composition and metabolism

For people with low levels of this important vitamin, supplements are often a first choice

OASIS trials: establishing effective doses Phase 2 OASIS 1 findings: Tested multiple dose levels: 0.3mg, 0.6mg, 1.2mg, 2.4mg, 4.5mg weekly Duration: 26 weeks Primary endpoint: Weight loss at each dose Dose-response results: 0.3mg weekly: ~4% body weight loss 0.6mg weekly: ~6% body weight loss 1.2mg weekly: ~8% body weight loss 2.4mg weekly: ~10% body weight loss 4.5mg weekly: ~12% body weight loss Key insight: Clear dose-response relationship